関連する実験動画

Updated: Feb 14, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

小児の膠芽細胞腫をターゲットに,OLIG2阻害剤CT-179を,患者から派生したオルソトップ性異種移植マウスモデルのパネルで分断放射線と組み合わせることで,小児の膠芽細胞腫をターゲットにしています

Holly Lindsay^1,2, Yuchen Du^1,3, Lin Qi^1,3,4

¹Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA.

International journal of molecular sciences

|February 13, 2026

まとめ

OLIG2阻害剤CT-179は,小児性高度の膠原腫 (pHGG) の治療に有望であることが示されています. この薬は血脳障壁を貫通し,放射線治療と併用すると,PHGG患者の生存率を向上させる可能性があります.

科学分野:

神経腫瘍学神経腫瘍学
分子生物学は分子生物学である.
薬理学薬理学とは

背景:

小児高度性膠原腫 (pHGG) は臨床的結果が悪いため,新たな治療戦略が必要である.
オリゴデンドロサイト系統転写因子2 (OLIG2) は,膠原腫幹細胞で高度に発現し,潜在的な治療標的である.
OLIG2阻害剤CT-179は,PHGG治療における有効性について評価されています.

研究の目的:

小児高度結晶腫 (pHGG) モデルにおけるOLIG2阻害剤CT-179の治療効果を評価する.
患者から派生した正方形異種移植 (PDOX) モデルにおけるOLIG2mRNA発現を決定する.
CT-179の脳内浸透および放射線治療 (XRT) との組み合わせ効果を含む,CT-179のインビトロおよびインビボ活性を評価する.

主な方法:

10つのPDOXモデルでOLIG2mRNA発現を決定した.
CT-179のXRTとXRTなしの単層および神経圏細胞におけるインビトロ活性を評価した.
腫瘍を有するPDOXマウスにおけるCT-179の脳内浸透率と,単独およびXRTと併用した体内での有効性を評価した.
Kaplan-Meier法を使用して生存データを分析しました.

主要な成果:

増加したOLIG2 mRNA発現は,PDOXモデル10種のうち7種で発見されました.
CT-179は,XRTによって活性化され,投与量と時間に依存した方法で細胞活性を抑制しました.
CT-179は,マウスの脳およびPDOX腫瘍に効果的に浸透することを実証しました.
CT-179とXRTの組み合わせは,4つのモデルのうち2つのモデルで,動物の生存期間を大幅に延長しました.

結論:

経口投与されたCT-179は,血脳障壁を貫通します.
CT-179は,特にXRTと組み合わせると,pHGGの成長を抑制する可能性があることを示しています.
pHGGの治療薬としてのCT-179のさらなる調査は正当化されています.

キーワード:

GBM GBM GBM GBM GBM GBM GBM GBM GBM GBM OLIG2 OLIG2 OLIG2は,OLIG2を構成するグループです.PDOXX PDOX は,PDOX を意味する.小児の脳腫瘍について放射線は,放射能を放射する.治療効果治療効果治療効果

さらに関連する動画

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

関連する概念動画

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Wood Panel Products

Wood Panel Products

Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...

Biological Effects of Radiation

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...